$6.31
0.32%
Nasdaq, Oct 02, 04:00 pm EDT. Closed.
ISIN
US74019P1084
Symbol
DTIL

Precision BioSciences, Inc. Target price 2026 - Analyst rating & recommendation

Precision BioSciences, Inc. Classifications & Recommendation

Buy
91%
Hold
9%

Precision BioSciences, Inc. Price Target

Target Price $20.40
Price $6.31
Potential
Number of Estimates 7
7 Analysts have issued a price target Precision BioSciences, Inc. 2027 . The average Precision BioSciences, Inc. target price is $20.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 10 Analysts recommend Precision BioSciences, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Precision BioSciences, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Precision BioSciences, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 34.26 13.21
50.13% 61.45%
EBITDA Margin -147.93% -510.50%
333.56% 245.10%
Net Margin -133.45% -738.52%
1,378.66% 453.41%

7 Analysts have issued a sales forecast Precision BioSciences, Inc. 2026 . The average Precision BioSciences, Inc. sales estimate is

$13.2m
unlock
. This is
70.69% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$17.1m 62.02%
unlock
, the lowest is
$10.6m 76.51%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $34.3m 50.13%
2026
$13.2m 61.45%
unlock
2027
$9.5m 28.17%
unlock
2028
$14.9m 56.99%
unlock
2029
$23.8m 59.66%
unlock
2030
$121m 408.83%
unlock
2031
$300m 148.07%
unlock
2032
$577m 92.26%
unlock
2033
$736m 27.56%
unlock

3 Analysts have issued an Precision BioSciences, Inc. EBITDA forecast 2026. The average Precision BioSciences, Inc. EBITDA estimate is

$-67.4m
unlock
. This is
89.28% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-69.4m 94.85%
unlock
, the lowest is
$-64.8m 81.86%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-50.7m 116.21%
2026
$-67.4m 33.03%
unlock
2027
$-82.0m 21.63%
unlock
2028
$-64.4m 21.52%
unlock
2029
$-95.0m 47.54%
unlock
2030
$918k 100.97%
unlock
2031
$146m 15,844.44%
unlock

EBITDA Margin

2025 -147.93% 333.56%
2026
-510.50% 245.10%
unlock
2027
-864.52% 69.35%
unlock
2028
-432.19% 50.01%
unlock
2029
-399.40% 7.59%
unlock
2030
0.76% 100.19%
unlock
2031
48.77% 6,317.11%
unlock

7 Precision BioSciences, Inc. Analysts have issued a net profit forecast 2026. The average Precision BioSciences, Inc. net profit estimate is

$-97.5m
unlock
. This is
84.98% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-84.1m 59.47%
unlock
, the lowest is
$-115m 117.60%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-45.7m 737.66%
2026
$-97.5m 113.34%
unlock
2027
$-73.0m 25.21%
unlock
2028
$-56.9m 22.03%
unlock
2029
$-53.8m 5.36%
unlock
2030
$1.3m 102.34%
unlock
2031
$58.4m 4,532.54%
unlock
2032
$86.3m 47.80%
unlock
2033
$122m 41.87%
unlock

Net Margin

2025 -133.45% 1,378.66%
2026
-738.52% 453.41%
unlock
2027
-769.03% 4.13%
unlock
2028
-381.97% 50.33%
unlock
2029
-226.40% 40.73%
unlock
2030
1.04% 100.46%
unlock
2031
19.45% 1,770.19%
unlock
2032
14.95% 23.14%
unlock
2033
16.63% 11.24%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -3.56 -3.69
442.31% 3.65%
P/E negative
EV/Sales 8.26

7 Analysts have issued a Precision BioSciences, Inc. forecast for earnings per share. The average Precision BioSciences, Inc. EPS is

$-3.69
unlock
. This is
81.77% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-3.18 56.65%
unlock
, the lowest is
$-4.34 113.79%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-3.56 442.31%
2026
$-3.69 3.65%
unlock
2027
$-2.76 25.20%
unlock
2028
$-2.15 22.10%
unlock
2029
$-2.04 5.12%
unlock
2030
$0.05 102.45%
unlock
2031
$2.21 4,320.00%
unlock
2032
$3.26 47.51%
unlock
2033
$4.63 42.02%
unlock

P/E ratio

Current -3.11 334.92%
2026
-1.71 44.99%
unlock
2027
-2.29 33.92%
unlock
2028
-2.93 27.95%
unlock
2029
-3.10 5.80%
unlock
2030
132.47 4,373.23%
unlock
2031
2.86 97.84%
unlock
2032
1.93 32.52%
unlock
2033
1.36 29.53%
unlock

Based on analysts' sales estimates for 2026, the Precision BioSciences, Inc. stock is valued at an EV/Sales of

and an P/S ratio of
13.19
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.42 84.57%
2026
8.26 241.17%
unlock
2027
11.49 39.23%
unlock
2028
7.32 36.30%
unlock
2029
4.59 37.37%
unlock
2030
0.90 80.35%
unlock
2031
0.36 59.69%
unlock
2032
0.19 47.98%
unlock
2033
0.15 21.64%
unlock

P/S ratio

Current 3.87 91.83%
2026
13.19 241.19%
unlock
2027
18.36 39.23%
unlock
2028
11.70 36.30%
unlock
2029
7.33 37.36%
unlock
2030
1.44 80.35%
unlock
2031
0.58 59.69%
unlock
2032
0.30 47.99%
unlock
2033
0.24 21.60%
unlock

Current Precision BioSciences, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
➜
Locked
Locked Aug 03 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Jul 09 2026
Oppenheimer
Locked
➜
Locked
Locked Jun 09 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked May 27 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked May 21 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Mar 28 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Mar 19 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Aug 03 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Jul 09 2026
Locked
Oppenheimer:
Locked
➜
Locked
Jun 09 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
May 27 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
May 21 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Mar 28 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Mar 19 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today